Good news: A national influenza vaccine program for under 5s!
这 Pharmaceuticals Benefits Advisory Committee (PBAC) has recommended the listing of quadrivalent influenza vaccine (QIV, Vaxigrip TetraTM) on the National Immunisation Program (NIP) for the prevention of seasonal influenza in children aged 6 months to <5 years as well as for individuals who are currently eligible for seasonal influenza vaccination through the NIP in 2020.
CVU last chance early bird tickets - secure your seat today!
This is just a reminder that early bird ticket sales for the next Clinical Vaccinology Update, end on 31st August 2019. From the 1st of September, tickets to the event will be available for $125 per person.
Follow the link below to secure your seat at a discounted price now!
New immunisation reference page: Tetanus prone wounds management
Tetanus, also known as lockjaw, is a serious bacterial infection caused by the bacteria Clostridium tetani. Tetanus causes severe muscle spasms and can be fatal. The bacteria live in soil, dust and animal faeces. Tetanus can be prevented by vaccination.
For further information and immunisation recommendations please refer to MVEC’s new immunisation reference page: 破伤风易发伤口处理